Reassessing Antidepressant Efficacy: A Meta-Analysis of Control Group Outcomes in SSRI, Psilocybin, and Esketamine Trials
Adults With Depression Likely Develop Physical Conditions 30% Faster
Significant Clinician-Level Differences Exist in Antidepressant Prescribing Patterns, Outcomes
Having Lower Personal Reserve Predicts Sustained Remission of Major Depression
Key Contributors to Long-term Outcomes for Patients With MDD
The Impact of Early Effective Treatment in MDD
Aligning MDD Treatment Goals for Payers and Patients
Supporting Adherence for Patients with MDD
Factors Affecting MDD Treatment Adherence
Population Health Approach in MDD
Social Determinants of Health in MDD: Part 2
MDD Treatment Disparities Across Patient Populations: Part 2
MDD Treatment Alternatives Explore Potential of Cannabis, Psychedelics
Which Depression Therapies Made the Updated US Guideline for Treating MDD?